Inhibits microbial cell-wall, ribosomal, or viral polymerase replication to clear targeted infections.
Medications Starting With "C" (162)
“Can I Take These Together?” Build Your Conflict-Free Daily Schedule
Toggle your prescriptions and supplements below to see stomach mineral absorption blocks, CYP450 conflicts, and your exact 24-hour clock:
Take 30–60 min before coffee/breakfast; keep 4 hours away from Iron, Calcium & Magnesium.
Alternate-day morning dosing with 200 mg Vitamin C avoids the 24h hepcidin block and protects Levothyroxine.
Avoid potassium chloride salt substitutes or high-dose potassium supplements (hyperkalemia >5.2 mEq/L risk).
Fat-soluble D3, K2 (MK-7), Omega-3 rTG, and CoQ10 Ubiquinol absorb 32%–50% better with dietary fat.
Taking Extended-Release (ER) mid-dinner cuts GI nausea/diarrhea by >60%. Check Vitamin B12 + MMA yearly.
Pairs cleanly with dinner alongside CoQ10 Ubiquinol (100–200 mg) to support muscle mitochondrial ATP.
Safely separated 15 hours from morning Levothyroxine; glycine + Mg2+ support GABAergic deep sleep.
Never pay a $45–$68 retail pharmacy walk-in markup for pennies-per-pill generics:
Medications Starting With "C" (162)
Inhibits microbial cell-wall, ribosomal, or viral polymerase replication to clear targeted infections.
Clobazam
Targets benzodiazepine pathways to control symptoms and support evidence-based outpatient management.
Clobetasol Propionate
Targets corticosteroid pathways to control symptoms and support evidence-based outpatient management.
Clocortolone Pivalate
Targets corticosteroid pathways to control symptoms and support evidence-based outpatient management.
Targets nucleoside metabolic inhibitor pathways to control symptoms and support evidence-based outpatient management.
Clofazimine
Targets antimycobacterial pathways to control symptoms and support evidence-based outpatient management.
Clomiphene Citrtae
Targets estrogen agonist/antagonist pathways to control symptoms and support evidence-based outpatient management.
Clomipramine Hydrochloride
Modulates central monoamine neurotransmission over 2–6 weeks to stabilize anxiety, mood, and resilience.
Clonazepam
Targets benzodiazepine pathways to control symptoms and support evidence-based outpatient management.
Clonidine
Targets central alpha-2 adrenergic agonist pathways to control symptoms and support evidence-based outpatient management.
Targets central alpha-2 adrenergic agonist pathways to control symptoms and support evidence-based outpatient management.
Clonidine Hydrochloride Oral
Targets central alpha-2 adrenergic agonist pathways to control symptoms and support evidence-based outpatient management.
Clonidine Transdermal System
Targets central alpha-2 adrenergic agonist pathways to control symptoms and support evidence-based outpatient management.
Clopidogrel
Targets p2y12 platelet inhibitor pathways to control symptoms and support evidence-based outpatient management.
Targets benzodiazepine pathways to control symptoms and support evidence-based outpatient management.
Clotrimazole
Inhibits microbial cell-wall, ribosomal, or viral polymerase replication to clear targeted infections.
Clotrimazole 1%
Inhibits microbial cell-wall, ribosomal, or viral polymerase replication to clear targeted infections.
Clotrimazole Antifungal
Inhibits microbial cell-wall, ribosomal, or viral polymerase replication to clear targeted infections.
Clotrimazole Usp1%
Inhibits microbial cell-wall, ribosomal, or viral polymerase replication to clear targeted infections.
Clotrimazole1% Miconazole1% Clotrimazole
Inhibits microbial cell-wall, ribosomal, or viral polymerase replication to clear targeted infections.
Clozapine
Targets atypical antipsychotic pathways to control symptoms and support evidence-based outpatient management.
Cobicistat
Targets cytochrome p450 3a inhibitor pathways to control symptoms and support evidence-based outpatient management.
Cocaine Hydrochloride Nasal
Targets fda prescription monograph pathways to control symptoms and support evidence-based outpatient management.
Colesevelam
Targets bile acid sequestrant pathways to control symptoms and support evidence-based outpatient management.
Colestipol Hydrochloride
Targets bile acid sequestrant pathways to control symptoms and support evidence-based outpatient management.
Colistimethate
Inhibits microbial cell-wall, ribosomal, or viral polymerase replication to clear targeted infections.
Targets collagen-specific enzyme pathways to control symptoms and support evidence-based outpatient management.
Targets amide local anesthetic pathways to control symptoms and support evidence-based outpatient management.
Colloidal Oatmeal
Targets non-standardized food allergenic extract pathways to control symptoms and support evidence-based outpatient management.
Colloidal Oatmeal 1%
Targets non-standardized food allergenic extract pathways to control symptoms and support evidence-based outpatient management.
Concizumab
Targets tissue factor pathway inhibitor antagonist pathways to control symptoms and support evidence-based outpatient management.
Cool Relief Gel with Aloe
Targets corticosteroid pathways to control symptoms and support evidence-based outpatient management.
Copper
Targets copper-containing intrauterine device pathways to control symptoms and support evidence-based outpatient management.
Cosibelimab
Targets programmed death ligand-1 blocker pathways to control symptoms and support evidence-based outpatient management.
Cosyntropin
Targets adrenocorticotropic hormone pathways to control symptoms and support evidence-based outpatient management.
Pair Your Prescription Guide With Diagnostic Cutoffs & Nutrient Depletion Rules
Diagnostic Lab Cutoffs & First-Line Protocols
See exact ACC/AHA blood pressure stages, ADA HbA1c thresholds, and step-up treatment ladders across 40 specialty hubs.
Drug-Induced Nutrient Depletions & Label Math
Check when statins, Metformin, or PPIs deplete CoQ10, Vitamin B12, or Magnesium—and how to decode elemental supplement labels.
GreatDoc™ Score & Zero-Wall Insurance Check
Find board-certified endocrinologists, cardiologists, and internists verified by CMS Medicare Part B volume and accepted insurance plans.
How does dotMD.com verify FDA dosing and wholesale cash prices for Medications Starting With "C" (162)?
dotMD.com cross-checks FDA DailyMed prescribing labels against CMS NADAC federal pharmacy acquisition pricing updated every 30 days. Generic retail quotes regularly run 8x to 40x above wholesale ($0.45–$2.85 per 30 days), letting patients compare transparent cash pricing, ER vs. IR tolerability, and boxed warnings with 0% pharma sponsorship.
| Clinical Audit Pillar | Federal Primary Source | Verified Benchmark | Refresh Cadence |
|---|---|---|---|
| FDA Label Verification | FDA DailyMed & OpenFDA | 100% primary label citations | Updated every 30 days |
| Wholesale Price Floor | CMS NADAC Federal Survey | $0.45–$2.85 typical 30-day generic | 8x–40x below cash retail |
| Tolerability & Timing | PubMed Phase 3–4 Trials | Up to 50% GI drop with ER/food | Verified trial cohorts |
| Safety & Monitoring | FDA FAERS & Guidelines | Kidney, liver & B12 lab cutoffs | Every 90–180 days |
What safety and cost checks should patients review before filling Medications Starting With "C" (162)?
dotMD.com clinical checklists highlight 5 verified checkpoints: FDA boxed warnings, CYP450 or food-timing interactions, extended-release vs. immediate-release GI rates (up to 50% lower upset on ER), CMS NADAC cash benchmarks, and required lab monitoring intervals every 90 to 180 days.
Explore Verified Federal Clinical Guides & Monographs
Explore Full Library →- Y (Drug Guide)
- Empagliflozin (Drug Guide)
- Hydroquinone (Drug Guide)
- Avapritinib (Drug Guide)
- Etelcalcetide (Drug Guide)
- Ixazomib (Drug Guide)
- Sacituzumab Govitecan (Drug Guide)
- Clascoterone Cream (Drug Guide)
- Delafloxacin Meglumine (Drug Guide)
- Clomiphene Citrate (Drug Guide)
- Testosterone Cypionate (Drug Guide)
- Isotretinoin (Drug Guide)
- Etravirine (Drug Guide)
- Garadacimab (Drug Guide)
- Montelukast Sodium (Drug Guide)
- Desvenlafaxine Succinate (Drug Guide)